Drug Profile
Rosuvastatin/fenofibrate
Alternative Names: Crestor/TriCor; Tricor/CrestorLatest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories; AstraZeneca
- Class Antihyperlipidaemics; Fibric acid derivatives; Fluorobenzenes; Propionates; Small molecules; Sulfonamides
- Mechanism of Action HMG-CoA reductase inhibitors; Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Lipid metabolism disorders
Most Recent Events
- 11 Jul 2006 Preclinical trials in Lipid metabolism disorders in USA (PO)